Karyopharm announces changes to its clinical leadership team

Newton, mass., feb. 22, 2022 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq:kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced changes to its clinical leadership team, including the appointment of patricia judson, m.d.

KPTI Ratings Summary

KPTI Quant Ranking